Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Misra, U. K.
Right arrow Articles by Pizzo, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Misra, U. K.
Right arrow Articles by Pizzo, S. V.
(Journal of Leukocyte Biology. 2002;71:487-494.)
© 2002 by Society for Leukocyte Biology

Beryllium fluoride-induced cell proliferation: a process requiring P21ras-dependent activated signal transduction and NF-{kappa}B-dependent gene regulation

Uma Kant Misra, Govind Gawdi and Salvatore Vincent Pizzo

Department of Pathology, Duke University Medical Center, Durham, North Carolina

Correspondence: Salvatore V. Pizzo, M.D., Ph.D., Professor and Chairman of Pathology, Box 3712, Duke University Medical Center, Durham, NC 27710. E-mail: Pizzo001{at}mc.duke.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We studied the effect of beryllium fluoride on murine peritoneal macrophages and determined its effects on signal transduction and genetic regulation. At low concentration (1–5 nM), BeF2 caused an approximate twofold increase in [3H]thymidine uptake and cell number, but above 5 nM, it showed cytotoxic effects. BeF2 increased cellular inositol (1,4,5)trisphosphate (IP3) and [Ca2+]i about twofold. The rise in [Ca2+]i occurred consequent to release from IP3-sensitive Ca2+ stores and from influx, mainly via L-type channels. A significant increase in the levels of MEK1, ERK1, p38 MAPK, and JNK phosphorylation was observed in BeF2-exposed macrophages. The levels of NF-{kappa}B and CREB transcription factors and the proto-oncogenes c-fos and c-myc were also elevated significantly. Intracellular Ca2+ chelation blocked the effect of BeF2. We conclude that BeF2 at low concentration exerts its mitogenic effects in peritoneal macrophages by elevating [Ca2+]i, which triggers the activation of p21ras-dependent MAPK signaling cascades.

Key Words: mitogenesis • MAPK regulation • AlFn • CREB


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Beryllium metal and its salts are widely used in industrial processes, ranging from electronics and telecommunication to nuclear reactors and weapons [1 ]. The metal and its salts are carcinogenic in experimental animals and induce cell transformation in mammalian cell culture [1 2 3 4 5 6 ]. At the mechanistic level, beryllium salts bind to nucleoproteins and inhibit enyzmes involved in DNA synthesis and also induce gene mutations in cultured cells [1 2 3 4 , 7 8 9 10 ]. Not all beryllium salts induce the same effects, and beryllium fluorides (BeFn) represent a unique situation. BeFn, like aluminum fluorides (AlFn), have protean effects on signal transduction and energy metabolism; for example, BeFn inhibit ATPases [11 12 13 ]. BeFn and AlFn affect G-protein-dependent processes. The {alpha} subunit of heterotrimeric G proteins in the guanosine 5'-diphosphate (GDP)-bound form can be activated by AlFn or BeFn [14 15 16 17 18 ]. It is thought that the metal ion-fluoride complexes mimic the terminal phosphate of guanosine 5'-triphosphate (GTP), such that the structure of the G{alpha}-GDP-AlFn (or BeFn) complexes resembles that of the GTP-bound form of the protein [14 15 16 17 18 ]. Activation of purified G proteins by metal ion-fluoride complexes results in a change in the conformation of the G{alpha} subunit and release of Gß{gamma}, which promotes association of the G{alpha} subunits with effector molecules downstream of the G protein [14 15 16 17 18 ]. The lifetime of the interaction of these metal ion-fluoride complexes with G proteins, and hence of the activated G proteins, is influenced by several effectors including GTPase-activating proteins (GAPS) [16 17 18 ].

Mitogen activated protein kinases (MAPKs) are a family of Ser/Thr kinases that mediate intracellular signal transduction in response to various stimuli. MAPKs are involved in cellular stress responses and apoptosis [19 20 21 22 23 ] and are themselves activated by phosphorylation [19 20 21 22 ]. Three major MAPK families have been identified: the extracellular signal-regulated kinases (ERK1/2), the stress-activated protein kinases known as c-jun NH2-terminal kinases (JNK), and the p38 MAPKs [19 20 21 22 ]. Ras-dependent activation of MAPK kinases that activate ERK, (MEK)1 and 2, leads to activation of ERK1/2 [19 20 21 22 ]. This pathway provides a common route by which signals from different growth-factor receptors converge to activate major transcription factors such as activated protein-1 (AP-1) [19 20 21 22 23 ]. Ras also activates JNK, which plays a role in regulating AP-1 activity [24 ]. Variations in [Ca2+]i are a major determinant in the regulation of the Ras/MAPK pathway [19 20 21 22 23 ]. G-protein-dependent activation of phospholipase C results in hydrolysis of membrane phosphoinositides generating inositol (1,4,5)trisphosphate (IP3) and diacylglycerol (DAG) [25 , 26 ]. IP3 raises [Ca2+]i by binding to specific receptors on the endoplasmic reticulum (ER), thus mobilizing membrane-sequestered Ca2+ [25 , 26 ]. DAG is required for activating protein kinase C (PKC) [25 , 26 ].

Recently, we have observed that exposure of murine peritoneal macrophages to beryllium chloride (BeCl)2 increased [Ca2+]i levels in an IP3-independent manner and enhanced [3H]thymidine uptake in a calcium-dependent manner. In this study, we demonstrate that exposure of macrophages to BeFn alters calcium homeostatis and mitogenesis in a manner significantly different than that observed with BeCl2 treatment [27 ]. We show that in macrophages, BeFn at low concentration (<10 nM) increase [3H]thymidine uptake and cell number about twofold. Concomitantly, we observed a similar increase in the levels of phosphorylated MEK1, ERK1, p38 MAPK, and JNK. Inhibition of these kinases by specific inhibitors significantly attenuated the BeFn-induced effects described above. BeFn also affected the levels of the transcription factors, nuclear factor-{kappa}B (NF-{kappa}B) and cyclic AMP response element-binding (CREB) protein. The effects of BeFn are dependent on [Ca;2+]i levels, which at least in part are a consequence of IP3 generation. BeFn also triggered Ca2+ uptake by L-type channels.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials
The sources of thioglycollate, cell culture materials, [3H]thymidine, [3H]myoinositol, verapamil, eiconazole, 1,2-bis(O-aminophenyl-ethane-ethane)-N,N,N',N'-tetrraacetic acid-acetoxymethyl ester (BAPTA/AM), genestein, staurosporin, chelerythrin, manumycin A, SB 203580, PD98059, Fura-2/AM, U73122, and U0126 have been described previously [28 29 30 ]. BeF2 and BeCl2 were purchased from Alfa Aesar (Ward Hill, MA). Antibodies against phosphorylated MEK1, ERK1, p38 MAPK, and JNK were purchased from New England BioLabs (Mississauga, Ontario, Canada). Antibodies against c-fos protein, c-myc protein, CREB protein, and NF-{kappa}B protein were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Other chemicals used were procured locally and were of the highest available purity.

Determination of macrophage cell number after exposure to BeFn
Because increased DNA synthesis is normally associated with an increase in total cellularity, the number of macrophages before and after overnight exposure to varying concentrations of BeF2 was determined. Peritoneal macrophages were harvested from C57BL/6 mice three days after intraperitoneal injection of thioglycollate as described previously [29 ] and were allowed to adhere in six-well plates in RPMI-1640 medium containing 5% fetal bovine serum (FBS) for 2 h. The adhered cells were scraped carefully, centrifuged at 1200 rpm for 5 min, and suspended in 1.5 ml RMPI-1640 medium containing 0.2% bovine serum albumin (BSA) and 0.5 ml aliquots (2x105 cells) pipetted into 15 ml siliconized polypropylene tubes. To the respective tubes, a specified concentration of BeF2 was added, the contents mixed gently, and the tubes incubated overnight as above. After overnight incubation, 10 µl trypan blue solution was added to each tube, the tubes were gently shaken during incubation for 2 min, and a 10 µl aliquot was used for counting the number of cells by hemocytometers. In experiments where the modulation in cell numbers of BeF2-exposed macrophages by [Ca2+]i, MAPKs, or Ras was examined, the macrophages were treated with the intracellular calcium chelator BAPTA/AM (10 µM/30 min); U0126 (1 µM/10 min), a specific inhibitor of MEK1; PD98059 (50 µM/90 min), a specific inhibitor of ERK; or SB203580 (25 µM/30 min), a specific inhibitor of p38 MAPK, or manumycin A (25 µM/60 min), a specific inhibitor of farnesyltransferase [28 ]. The latter enzyme is required for activation of p21ras [28 ]. These agents were added to their respective tubes, which were incubated for the specified time before adding BeF2 (2 nM). Cell numbers were determined as described above.

[3H]Thymidine uptake by BeFn-exposed macrophages
Murine peritoneal macrophages (4x105 cells/well in 48-well plates) harvested as above were allowed to adhere for 2 h in RPMI-1640 medium containing 5% FBS, penicillin, streptomycin, and glutamine at 37°C in a humidified CO2 (5%) incubator. The monolayers were washed twice with Hanks’ balanced salt solution containing 10 mM HEPES, 3.5 mM NaHCO3, pH 7.2 (HHBSS). A volume of the above RPMI medium was added, except that sera was replaced with 0.2% BSA. [3H]Thymidine was then added, followed by varying concentrations of BeF2 or NaF. The cells were incubated overnight in a humidified CO2 (5%) incubator. The incubations were terminated by aspirating the medium and washing macrophages twice, first with 5% trichloroacetic acid (15 min/4°C) and then thrice with HHBSS. The monolayers were lysed with 1 N NaOH, and an aliquot was used for liquid scintillation counting and protein estimation [30 ].

The role of [Ca2+]i levels and the activity of PKC, phosphatidylinositol-specific phospholipase C (PI-PLC), tyrosine kinases, and MAPKs in BeFn-induced [3H]thymidine uptake
In experiments that examined effects of modulating [Ca2+]i levels in BeFn-induced [3H]thymidine uptake, [Ca2+]i levels were modulated with BAPTA/AM (10 µM/30 min) or nifedipine (5 µM/10 min). These agents were added to individual wells, and the cells were incubated for the specified time period before adding BeF2. In studies on modulation of [3H]thymidine uptake, the respective monolayers were preincubated with U73122 (4 µM/10 min), an inhibitor of PI-PLC; chelerythrin (200 nM/10 min), an inhibitor of PKC; genestein (20 µM/16 h), an inhibitor of tyrosine kinases, U0126(2 µM/10 min), an inhibitor of MEK1; PD 98059 (50 µM/90 min), an inhibitor of ERK; SB203580 (15 µM/30 min), an inhibitor of p38 MAPK; or manumycin A (10 µM/1 h), a farnesyltransferase inhibitor, before adding BeF2 and [3H]thymidine. Details of incubations and determination of cell lysate radioactivity were as described above.

Measurement of IP3
Murine peritoneal macrophages were obtained as described above. The cells were centrifuged, suspended in RPMI-1640 medium containing 12.5 units of penicillin/ml, 6.5 µg/ml streptomycin, 2 mM glutamine, and 5% FBS, plated in six-well plates (4x106 cells/well in six-well plates), and allowed to adhere for 2 h at 37°C in a humidified 5% CO2 incubator. Monolayers were washed with HHBSS, a volume of above-mentioned RPMI, except that serum was substituted with 0.2% fatty acid-free BSA added, followed by the addition of [3H]myoinositol (8 µCi/well), and the monolayers were incubated overnight as described above. The monolayers were washed with chilled HHBSS containing 10 mM LiCl, 1 mM CaCl2, and 1 mM MgCl2 thrice, a volume of wash buffer was added, and monolayers were preincubated for 3 min at 37°C as above, before stimulating with BeF2 (2 nM) or with aluminum chloride (10 µM)-sodium fluoride (50 mM). Other details of fractionation and quantification of radioactivity of IP3 were performed as described previously [29 ].

Measurements of changes in intracellular calcium levels in BeFn-exposed macrophages
Changes in [Ca2+]i levels in Fura-2/AM-loaded macrophages on exposure to BeF2 were measured by digital imaging microscopy essentially as described previously [29 ]. Briefly, freshly harvested murine peritoneal macrophages were suspended in RPMI-1640 medium containing 5% FBS, penicillin, streptomycin, and glutamine. They were then allowed to adhere on glass coverslips and kept in 35-mm petri dishes at 37°C for 2 h in a humidified CO2 (5%) incubator. The nonadherent cells were aspirated, and the monolayer was washed with HHBSS, a volume of RPMI medium was added, and cells were incubated overnight as above. Macrophages incubated overnight were loaded with Fura-2/AM (4 µM/30 min at 25°C in dark) and washed thrice with HHBSS, and a volume of HHBSS was added. The cells on coverslips were exposed to BeF2, and changes in [Ca2+]i in single cells were quantified as described previously [29 ]. The origin of elevated levels of [Ca2+]i in BeF2-exposed cells could result from its elevated release from IP3-sensitive Ca2+ stores, influx of extracellular Ca2+ via specific channels, IP3-independent release from ER Ca2+ stores, and/or inhibition of [Ca2+]i extrusion. The contribution of IP3-dependent release of Ca2+ from ER calcium stores to the total [Ca2+]i pool in BeF2-exposed macrophages was analyzed by treating Fura-2/AM-loaded cells with PI-PLC inhibitor U73122 (4 µM/10 min) before adding BeF2 and measuring changes in Fura-2 fluorescence [31 ]. The contribution of BeF2-induced influx of Ca;2+ to the total [Ca2+]i pool in BeF2-exposed cells was assessed by treating the cells with nifedipine (5 µM/10 min), specific blockers of L-type Ca2+ channel [32 ], or flunarizine HCl (5 µM/10 min), a selective blocker of low-threshold T-type channel, before exposure to BeF2 and measurement of changes in Fura-2 fluorescence.

Western blotting of phosphorylated MEK1, ERK1, p38 MAPK, and JNK in macrophages exposed to BeFn
Freshly harvested peritoneal macrophages in RPMI-1640 medium containing penicillin, streptomycin, glutamine, and 5% FBS were allowed to adhere in six-well plates (3x106 cells/well) for 2 h as above. The monolayers were washed twice with HHBSS, and a volume of above-mentioned RPMI-1640 medium was added, except that the serum was substituted with 0.2% BSA, and plates were incubated overnight as above. The monolayers were washed twice, and a volume of RMPI medium containing 0.2% BSA was added. The cells were then exposed to buffer or BeF2 (2 nM/20 min) after adding the specific inhibitors/modulators of MAPKs. The concentrations of these inhibitors and the incubation time periods were as described above. The incubations were terminated by aspirating the medium. The lysis of cells, their electrophoresis, and Western immunoblotting were performed according to the manufacturer’s instruction. In each case, equal amounts of protein were used for electrophoresis. The detection of phosphorylated MAPKs by enhanced chemifluorescence (ECF) and quantification of their distribution were performed by PhosphorimagerTM (Storm 860, Molecular Dynamics, Sunnyvale, CA).

Western blotting of c-fos, c-myc, CREB, and NF-{kappa}B proteins in macrophages exposed to BeFn
Freshly harvested peritoneal macrophages in RPMI-1640 medium containing penicillin, streptomycin, glutamine, and 5% FBS were allowed to adhere in six-well plates (3x106 cells/well) for 2 h as above. The monolayers were washed twice with HHBSS, and a volume of RPMI-1640 medium was added, except that the serum was substituted with 0.2% BSA, and plates were incubated overnight as above. The monolayers were washed, a volume of RPMI medium containing 0.2% BSA was added, and the cells were exposed to buffer or to BeF2 (2 nM/20 min). The respective incubations were terminated by aspirating the medium. The lysis of cells, their electrophoresis, and Western immunoblotting were done according to the manufacturer’s instruction. In each case, an equal amount of protein was used for electrophoresis. The detection of immunoblots was performed by ECF and quantification of their distribution by PhosphorimagerTM (Storm 860, Molecular Dynamics).

Measurement of the effect of NF-{kappa}B activation on BeFn-induced [3H]thymidine incorporation
The involvement of the NF-{kappa}B transcription factor in BeFn-induced uptake was examined by incubating the cells with two specific inhibitors of NF-{kappa}B, namely BAY 11-7082 (10 µM/10 min) [33 ] and PGA1 (25 µM/10 min) [34 ]. These inhibitors prevent agonist-induced phosphorylation and degradation of I{kappa}B, resulting in the inactivation of NF-{kappa}B activation, and hence, inhibit its translocation to nuclei [35 36 37 ]. These inhibitors were added to respective monolayers and incubated for the specified time before adding BeF2. Details of incubation and determination of cell lysate radioactivity were the same as described above. Statistical analysis of the data was performed by Student’s t-test, and P values <=0.05 are considered significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The effect of BeFn exposure on cell division and [3H]thymidine uptake in peritoneal macrophages
Over the concentration range of 1–5 nM, BeF2 caused an increase in cell numbers, which at 2 nM, was about twofold (Fig. 1 A ). This was paralleled at this concentration by a similar increase in [3H]thymidine uptake (Fig. 1B) . Above this range, there was a decline in cell numbers and [3H]thymidine uptake. The latter results suggest that cell cytotoxicity occurs above a BeF2 concentration of 5 nM. Because fluoride itself is toxic, we examined the effect of adding NaF to the macrophages. Below a concentration of 100 nM, NaF did not affect [3H]thymidine uptake (Fig. 1C) . Above this concentration, some reduction in uptake of [3H]thymidine did occur. Trypan blue uptake by macrophages also increased at higher concentrations of BeF2 (unpublished results). We conclude that the effects of BeFn species at higher concentration on cell division are most likely the effect of beryllium-induced toxicity.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. BeF2-induced cell division and [3H]thymidine incorporation into peritoneal macrophages. (A) Effect of increasing concentration of BeF2 on murine peritoneal macrophage cell number after 24 h incubation. The cell numbers are mean ± SE from two independent experiments counted in quadruplicate. (B) Effect of increasing concentrations of BeF2 on [3H]thymidine incorporation into macrophages. Values are mean ± SE from two experiments performed in quadruplicate and are expressed as fmol [3H]thymidine incorporated/mg cellular protein. The experimental data were significantly different at P < 0.005 compared with buffer-treated controls. (C) Effect of increasing concentrations of NaF on [3H]thymidine incorporation in macrophages. Values are mean ± SE from two experiments performed in quadruplicate and are expressed as fmols [3H]thymidine incorporation/mg cellular protein.

 
The effect of BeFn exposure of macrophages on phosphoinositide hydrolysis
Cleavage of membrane phosphoinositides by PI-PLC results in a transient increase in IP3, which interacts with specific ER receptors to cause an increase in cytosolic-free Ca2+ [25 , 26 ]. Cytosolic-free Ca2+ is involved in the regulation of specific cell-cycle events and DNA synthesis [38 39 40 ]. BeFn- or AlFn-exposed macrophages demonstrated a transient increase in IP3 of 25 ± 5% and 50 ± 10%, respectively, within 5–10 s of treatment. The results with BeFn are significant in two respects: The concentration of BeFn (2 nM) used was far less than AlFn (10 µM). Moreover, BeCl2-treated macrophages do not show an effect on IP3 synthesis even at much higher concentrations [27 ].

The effect of BeFn exposure of macrophages on [Ca2+]i
Exposure of macrophages to BeFn species increased [Ca2+]i levels by two- to threefold (Fig. 2 A ). The increase was largely in single, large spikes, sometimes accompanied by smaller spikes. The effect of BeF2 is concentration-dependent, and a maximal effect is seen at 2–5 nM. Thereafter, responses declined and were essentially absent above 50 nM concentrations of BeF2 (Fig. 2B) . By contrast, macrophages exposed to BeCl2 show an increase in [Ca2+]i, which reaches a plateau at 100 nM, and the response is sustained thereafter, up to a concentration of at least 500 nM BeCl2 in the absence of IP3 synthesis [27 ].



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Changes in [Ca2+]i in Fura-2/AM-loaded macrophages exposed to BeF2. (A) A representative cell from 100–150 cells from five individual experiments each using 25–30 cells showing an increase in [Ca2+]i on exposure to BeF;2 (2 nM). In these studies, 75–85% of cells showed a positive response. The increase occurred as a single spike, multiple spikes, or as a sustained response. (B) Effect of increasing concentrations of BeF2 on changes in [Ca2+]i in Fura-2/AM-loaded macrophages. The values are mean ± SE of changes in individual cells [Ca2+]i at 2 min after addition of BeF2 from two experiments each using 25–30 cells. The arrow in (A) indicates the time of addition of BeF2.

 
To further assess the contribution of IP3-dependent mechanisms in raising [Ca2+]i, we used U73122, an inhibitor of PI-PLC. Cells pretreated with U73122 prior to addition of BeF2 showed a 30–40% decrease in the [Ca2+]i response compared with cells treated only with BeF2 (Fig. 3A and B). These results are consistent with the hypothesis that BeFn treatment triggers IP3-dependent increases in [Ca2+]i. However, IP3-independent mechanisms for mobilizing Ca2+ are also activated by BeFn and appear to account for 60–70% of the increase in free cytosolic Ca2+. Therefore, we used Ca2+ channel blockers to confirm this hypothesis. Nifedipine (5 µM), which blocks L-type channels, blunted the rise in [Ca2+]i, and flunarizine HCl, which blocks T-type channels, had no effect (Fig. 3C and 3D) . We conclude from these studies that BeFn increase [Ca2+]i by IP3-dependent and -independent mechanisms, the latter of which involves L-type Ca2+ channels.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 3. Modulations of BeF2-induced increase in [Ca2+]i in Fura-2/AM-loaded macrophages. (A) Oscillatory increases in [Ca2+]i in macrophages exposed to BeF2 (2 nM). (B) Effect of PI-PLC inhibitor U73122 (4 µM/10 min) on BeF2-induced increase in [Ca2+]i. (C) Effect of L-type Ca2+ channel-blocker nifedipine (5 µM) on BeF2-induced increase in [Ca2+]i. (D) Effect of T-type Ca2+ channel-blocker flunarizine HCl (5 µM) on BeF2-induced increase in [Ca2+]i. The inhibitors were present during Ca2+ measurements. The data shown in each case are representative of two to three individual experiments, each using 20–25 cells.

 
Elevated cytosolic Ca2+ and BeFn-induced macrophage proliferation
Because cytosolic-free Ca2+ regulates specific cell-cycle events and DNA synthesis [37 , 38 ], we next studied the effect of modulating [Ca2+]i on BeFn-induced increases in cell number and [3H]thymidine uptake (Fig. 4 ). Modulation of Ca2+ in BeF2-treated macrophages with BAPTA/AM or nifedipine decreased cell numbers significantly and inhibited [3H]thymidine incorporation (Fig. 4A and 4B) . Likewise, limiting the availability of IP3 by inhibiting PI-PLC with U73122 also resulted in a 30–40% reduction in [3H]thymidine uptake by BeF2-treated cells (Fig. 4C) . We conclude that BeFn-induced cell proliferation is dependent on the availability of cytosolic Ca2+. Generally, elevations of [Ca2+]i cause membrane localization and activation of PKC, which then initiate protein phosphorylation-dependent cellular events [26 ]. Therefore, studies were performed to understand the role of PKC in BeF2-treated macrophages and cell proliferation. Chelerythrin and staurosporin treatment significantly decreased the effect of BeF2 exposure on macrophage uptake of [3H]thymidine (Fig. 4C) . These studies demonstrate that PKC activity is important in the mechanism of BeFn-induced macrophage proliferation.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Modulations of BeF2-induced increase in macrophage cell number and [3H]thymidine incorporation. (A) Effect of MAPK inhibitors and [Ca2+]i chelators on BeF2-induced increase in macrophage cell number. The respective inhibitors were added to the cultures, and the cells were incubated for the indicated time before adding BeF2, which was present during the overnight incubation. The bars are: (1) buffer, (2) BeF2 (2 nM), (3) U0126 (1 µM/10 min) + BeF2, (4) PD98059 (50 µM/90 min) + BeF2, (5) SB203580 (15 µM/30 min) + BeF2, (6) manumycin A (10 µM/60 min) + BeF2, and (7) BAPTA/AM (10 µM/30 min) + BeF2. The data presented are from two experiments performed in quadruplicate and are expressed as mean ± SE. (B) Effect of Ca2+ chelators, PKC, tyrosine kinases, and MAPK inhibitors on BeF2-induced increase in [3H]thymidine incorporation into macrophages. The respective inhibitors were added to monolayers, and the cells were incubated for the indicated time before adding BeF2, which was present during the overnight incubation. The bars are: (1) buffer, (2) BeF2 (2 nM), (3) BAPTA/AM (10 µM/30 min) + BeF2, (4) chelerythrin (200 nM/10 min) + BeF2, (5) genestein (20 µM/16 h) + BeF2, (6) PD98059 (50 µM/90 min) + BeF2, and (7) SB 203580 (15 µM/30 min) + BeF2. The results are the mean ± SE from two to three experiments performed in quadruplicate. (C) Effect of inhibition of IP3 generation, L-type Ca2+ channels, ERK1, and NF-{kappa}B activation on BeF2-induced increase in [3H]thymidine incorporation. The bars are: (1) buffer, (2) BeF2 (2 nM), (3) U73122 (4 µM/10 min) + BeF2, (4) BAY 11-7082 (25 µM/10 min) + BeF2, (5) PGA1 (25 µM/10 min) + BeF2, (6) nifedipine (5 µM/10 min) + BeF2, and (7) U0126 (1 µM/10 min) + BeF2. The results are mean ± SE from two experiments performed in quadruplicate and are expressed as [3H]thymidine incorporated/mg cellular protein. [3H]Thymidine incorporation into cells treated with various inhibitors used above in the absence of BeF2 was comparable with or only slightly lower than the buffer-treated cells. The data are significantly different at the 5% level compared with vehicle-treated controls. (*P < 0.05).

 
Signal-transduction mechanisms of BeFn-induced macrophage proliferation
Distinct signaling pathways mediate mitogenic signals induced by a variety of hormones, growth factors, or heavy metals [19 20 21 22 23 ]. Significant convergence of signals from receptor tyrosine kinases and G-protein-coupled receptors occurs at the level of MAPKs [19 20 21 22 23 ] Therefore, we next studied the involvement of p21ras-dependent MAPKs in BeFn-induced cell proliferation (Fig. 4C) . The involvement of protein phosphorylation was evaluated by use of genestein, and manumycin A was used to inhibit farnesyltransferase. The latter is required for p21ras activation [41 ]. Both inhibitors nearly abolished the effect of BeF2 on macrophage proliferation. Ras mediates its effects on cellular proliferation in part by activation of a cascade of protein kinases [19 20 21 22 23 ]. Therefore, we probed such events by using a variety of inhibitors including U0126 (MEK1), PD98059 (ERK1/2), and SB203580 (p38 MAPK). All three compounds decreased BeF2-induced macrophage proliferation significantly (Fig. 4C) .

The next series of studies directly examined the effects of BeF2 on the phosphorylation of several of the components of the p21ras-dependent MAPK pathway (Fig. 5 ). Specifically, MEK1 (Fig. 5A and 5B) , ERK1 (Fig. 5C and 5D) , p38 MAPK (Fig. 5E and 5F) , and JNK (Fig. 5G and 5H) phosphorylation was examined. In each case, BeF2-exposed macrophages demonstrated an approximate twofold increase in phosphorylation of these proteins. Pretreatment with BAPTA/AM abolished the action of BeF2 on up-regulating protein phosphorylation.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 5. Activation of MAPKs in macrophages by BeF2 and the role of [Ca2+]i. The activation of MEK1 (A and B), ERK1 (C and D), p38 MAPK (E and F), and JNK (G and H) is presented as immunoblots (A, C, E, and G), and their quantitative distribution is as measured by PhosphorimagerTM (B, D, F, and H). Immunoblots are representative of at least three separate experiments. (A and B) Activation of MEK1. The bars are: (1) buffer, (2) BeF2 (2 nM), and (3) BAPTA/AM + BeF2. (C and D) Activation of ERK1. The bars are: (1) buffer, (2) BeF2, and (3) BAPTA/AM + BeF2. (E and F) Activation of p38 MAPK. The bars are: (1) buffer, (2) BeF2, and (3) BAPTA/AM + BeF2. (G and H) Activation of JNK. The bars are: (1) buffer, (2) BeF2, and (3) BAPTA/AM + BeF2.

 
BeFn exposure and NF-{kappa}B regulation in macrophages
In response to a variety of stimuli, including viral and bacterial pathogens, cytokines, and stress-activating agents, the latent cytoplasmic NF-{kappa}B/I{kappa}B complex is activated by phosphorylation of I{kappa}B [35 36 37 ]. This targets I{kappa}B for ubiquitination and proteosomal degradation releasing NF-{kappa}B [35 , 36 ]. Thus, NF-{kappa}B is activated and able to translate to the nucleus where it stimulates gene transcription [35 36 37 ]. Therefore, we examined the effect of BeFn on macrophages with respect to NF-{kappa}B activation. BeF2 addition caused about a twofold increase in NF-{kappa}B activation, as determined by quantifying Western blots of macrophage extracts (Fig. 6A and B). Next, we pretreated BeF2-exposed macrophages to two specific inhibitors of I{kappa}B phosphorylation, BAY 11-7082 and PGA1. Both agents also significantly decreased the effect of BeF2 on increasing [3H]thymidine uptake (Fig. 4B) .



View larger version (35K):
[in this window]
[in a new window]
 
Figure 6. Activation of transcription factors and expression of early genes in macrophages exposed to BeF2. The activation of NF-{kappa}B (A and B) and CREB (C and D) is presented as immunoblots (A and C) and their quantitative distribution (B and D). The expression of early genes c-fos (E and F) and c-myc (G and H) is presented as immunoblots (E and G) and their quantitative distribution (F and H). Immunoblots are representative of three separate experiments. (A and B) Activation of NF-{kappa}B. The bars are: (1) buffer and (2) BeF2. (C and D) Activation of CREB. The bars are: (1) buffer and (2) BeF2. (E and F) Induction of c-fos expression. The bars are: (1) buffer, (2) BeF2, and (3) BAPTA/AM + BeF2. (G and H) Induction of c-myc expression. The bars are: (1) buffer, (2) BeF2, and (3) BAPTA/AM + BeF2.

 
BeFn exposure and transcription-factor CREB regulation in macrophages
Many signaling pathways stimulate transcription of target genes through nuclear factors whose activities are regulated primarily by phosphorylation [23 ]. Cyclic AMP regulates the expression of numerous genes through protein kinase A-dependent phosphorylation of transcription factor CREB [42 , 43 ]. Exposure of macrophages to BeF2 increased CREB protein levels about twofold (Fig. 6C and 6D) . These results suggest the involvement of cAMP signaling in BeFn-induced mitogenesis in macrophages.

BeFn exposure and regulation of c-fos and c-myc proteins in macrophages
When quiescent cells enter the cell cycle, expression of early response genes is necessary for progression through G1 and subsequent proliferation [44 ]. Many of these are proto-oncogenes that encode nuclear transcription factors, which determine subsequent expression of other genes [45 ]. Expression of c-fos is part of a mitogenic response that is required for cell proliferation [45 ]. Transcription of the c-fos gene is regulated in part by cAMP-response element and serum-response element [42 , 43 ]. Increased [Ca2+]i can activate c-fos transcription through the latter mechanism, and a rise in nuclear Ca2+ can activate c-fos transcription through CREB phosphorylation [42 , 43 ]. c-myc is effective in transcriptional activation and cell-cycle progression [46 ]. In view of the effects of BeF2 treatment of macrophages described above, we examined the effects of this agent on the expression of c-fos and c-myc genes. Exposure of peritoneal macrophages to BeF2 (2 nM) caused a 1.5- to twofold increase in the expression of c-fos and c-myc proteins (Fig. 6A 6B 6C 6D) . Ca2+ chelation by BAPTA/AM abolished this effect.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, we have demonstrated that low concentrations of FeFn species (1–5 nM) are mitogenic, and higher concentrations appear to be cytotoxic to macrophages. The studies support the hypothesis that these effects are mediated through the ability of BeFn to increase cytosolic-free Ca2+ by IP3-dependent and -independent mechanisms. The latter effects are mediated by L-type Ca2+ channels. We propose that the effect of BeFn on IP3 synthesis is mediated by the ability of BeFn to bind to and affect heterotrimeric G proteins. As noted above, like AlFn, BeFn can mimic the terminal phosphate of GTP in the G{alpha}-GDP-BeFn complex [14 15 16 17 18 ]. The effects demonstrated here contrast to those seen in BeCl2-exposed macrophages [27 ]. This agent can also cause an increase in [Ca2+]i in macrophages; however, the effect is exclusively the result of entry of extracellular Ca2+ into the cells [27 ]. BeCl2-exposed macrophages show no increase in IP3 levels at concentrations equal to or far higher than the concentrations of BeF2 studied in the current analysis [27 ]. Moreover, BeCl2 treatment does not in itself increase PKC activity [27 ]. The data suggest that by activating G proteins, BeFn trigger a series of events not unlike ligands, which via receptor-binding, activate G proteins [14 15 16 17 18 ]. Subsequently, phosphoinositide degradation produces IP3 and DAG [25 , 26 ]. The former mobilizes Ca2+ from the ER via direct interactions with its receptors, which contain a Ca2+ channel [25 , 26 ]. DAG activates PKC in the presence of Ca2+ [25 , 26 ]. The data further indicate that these events activate p21ras-dependent MAPK pathways and promote translocation of critical signaling components to the nucleus, which in turn, promote early gene activation in macrophages, thus accounting for the proproliferative effect of BeFn species on macrophages. These effects occur at very low concentrations of BeFn. The majority of the effects shown here was seen at concentrations of only 2 nM BeF2. This contrasts to much higher levels of AlFn (µM) required to affect IP3 synthesis and subsequent effects. At higher concentrations, however, BeF2 exerts its cytotoxic and genotoxic effects. The mechanism(s) of BeF2 cytotoxicity and genotoxicity may be many but may include its direct binding to the macromolecules as well as modulation of signal-transduction cascades.

It is unclear whether BeFn species are likely to be present in the environment. However, fluoride is widely available in the environment because it is added to water to harden tooth enamel. Given the low concentrations of BeFn, which induce the changes seen here, further studies might be warranted to determine the potential for environmental generation of BeFn species. This may be relevant particularly at this time, because increased amounts of beryllium are entering the environment as a result of extensive use in fiber optics, cellular communication network systems, and semiconductors [1 ].


    ACKNOWLEDGEMENTS
 
This work was supported by research grant HL 24066 from the National Heart, Lung, and Blood Institute.

Received August 29, 2001; revised August 29, 2001; accepted October 11, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. National Toxicology Program 1998 U.S. Department of Health and Human Services
  2. Leonard, A., Lauwerys, R. (1987) Mutagenicity, carcinogenicity and teratogenicity of beryllium Mutat. Res. 186,35-42[Medline]
  3. Nickell-Brady, C., Hahn, F. F., Finch, G. L., Belinsky, S. A. (1994) Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors Carcinogenesis 15,257-262[Abstract/Free Full Text]
  4. Ashby, J., Ishidate, M., Jr, Stoner, G. D., Morgan, M. A., Ratpan, F., Callander, R. D. (1990) Studies on the genotoxicity of beryllium sulphate in vitro and in vivo Mutat. Res. 240,217-225[Medline]
  5. Newman, L. S. (1993) To Be2+ or not to Be2+: immunogenetics and occupational exposure Science 262,197-198[Free Full Text]
  6. Skilleter, D. N., Price, R. J., Legg, R. F. (1983) Specific G1-S phase cell cycle block by beryllium as demonstrated by cytofluorometric analysis Biochem. J. 216,773-776[Medline]
  7. Witschi, H. P. (1970) Effects of beryllium on deoxyribonucleic acid-synthesizing enzymes in regenerating rat liver Biochem. J. 120,623-634[Medline]
  8. Luke, M. Z., Hamilton, L., Hollocher, T. C. (1975) Beryllium-induced misincorporation by a DNA polymerase: a possible factor in beryllium toxicity Biochem. Biophys. Res. Commun. 62,497-501[Medline]
  9. Skilleter, D. N., Price, R. J. (1980) Apparent two phase beryllium labelling of hepatic cell nuclei isolated after intravenous administration of beryllium compounds to rats. A possible explanation Arch. Toxicol. 45,75-80[Medline]
  10. Combeau, C., Carlier, M. F. (1988) Probing the mechanism of ATP hydrolysis on F-actin using vanadate and the structural analogs of phosphate BeF-3 and A1F-4 J. Biol. Chem. 263,17429-17436[Abstract/Free Full Text]
  11. Issartel, J. P., Dupuis, A., Lunardi, J., Vignais, P. V. (1991) Fluoroaluminum and fluoroberyllium nucleoside diphosphate complexes as probes of the enzymatic mechanism of the mitochondrial F1-ATPase Biochemistry 30,4726-4733[Medline]
  12. Phan, B. C., Faller, L. D., Reisler, E. (1993) Kinetic and equilibrium analysis of the interactions of actomyosin subfragment-1. ADP with beryllium fluoride Biochemistry 32,7712-7719[Medline]
  13. Sankaran, B., Bhagat, S., Senior, A. E. (1997) Inhibition of P-glycoprotein ATPase activity by beryllium fluoride Biochemistry 36,6847-6853[Medline]
  14. Sternweis, P. C., Gilman, A. G. (1982) Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride Proc. Natl. Acad. Sci. USA 79,4888-4891[Abstract/Free Full Text]
  15. Antonny, B., Chabre, M. (1992) Characterization of the aluminum and beryllium fluoride species which activate transducin. Analysis of the binding and dissociation kinetics J. Biol. Chem. 267,6710-6718[Abstract/Free Full Text]
  16. Kahn, R. A. (1991) Fluoride is not an activator of the smaller (20-25 kDa) GTP-binding proteins J. Biol. Chem. 266,15595-15597[Abstract/Free Full Text]
  17. Diaz, J. F., Sillen, A., Engelborghs, Y. (1997) Equilibrium and kinetic study of the conformational transition toward the active state of p21Ha-ras, induced by the binding of BeF3- to the GDP-bound state, in the absence of GTPase-activating proteins J. Biol. Chem. 272,23138-23143[Abstract/Free Full Text]
  18. Mittal, R., Ahmadian, M. R., Goody, R. S., Wittinghofer, A. (1996) Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins Science 273,115-117[Abstract]
  19. Kolch, W. (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions Biochem. J. 351,289-305
  20. Widmann, C., Gibson, S., Jarpe, M. B., Johnson, G. L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human Physiol. Rev. 79,143-180[Abstract/Free Full Text]
  21. Brunet, A., Pouyssegur, J. (1997) Mammalian MAP kinase modules: how to transduce specific signals Essays Biochem 32,1-16[Medline]
  22. Wilkinson, M. G., Millar, J. B. (2000) Control of the eukaryotic cell cycle by MAP kinase signaling pathways FASEB J 14,2147-2157[Abstract/Free Full Text]
  23. Treisman, R. (1996) Regulation of transcription by MAP kinase cascades Curr. Opin. Cell Biol. 8,205-215[Medline]
  24. Rausch, O., Marshall, C. J. (1997) Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway Mol. Cell. Biol. 17,1170-1179[Abstract]
  25. Berridge, M. J. (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers Annu. Rev. Biochem. 56,159-193[Medline]
  26. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 258,607-614[Abstract/Free Full Text]
  27. Misra, U. K., Gawdi, G., Pizzo, S. V., Lewis, J. G. (1999) Exposure of cultured murine peritoneal macrophages to low concentrations of beryllium induces increases in intracellular calcium concentrations and stimulates DNA synthesis J. Leukoc. Biol. 65,786-791[Abstract]
  28. Misra, U. K., Gawdi, G., Gonzalez-Gronow, M., Pizzo, S. V. (1999) Coordinate regulation of the alpha(2)-macroglobulin signaling receptor and the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor by insulin J. Biol. Chem. 274,25785-25791[Abstract/Free Full Text]
  29. Misra, U. K., Chu, C. T., Rubenstein, D. S., Gawdi, G., Pizzo, S. V. (1993) Receptor-recognized alpha 2-macroglobulin-methylamine elevates intracellular calcium, inositol phosphates and cyclic AMP in murine peritoneal macrophages Biochem. J. 290,885-891
  30. Misra, U. K., Gonzalez-Gronow, M., Gawdi, G., Pizzo, S. V. (1997) Upregulation of the {alpha}2-macroglobulin signaling receptor on rheumatoid synovial fibroblasts J. Biol. Chem. 272,497-502[Abstract/Free Full Text]
  31. Yule, D. I., Williams, J.A. (1992) U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells J. Biol. Chem. 267,13830-13835[Abstract/Free Full Text]
  32. Godfraind, T., Miller, R., Wibo, M. (1986) Calcium antagonism and calcium entry blockade Pharmacol. Rev. 38,321-416[Medline]
  33. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., Gerritsen, M. E. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272,21096-21103[Abstract/Free Full Text]
  34. Rossi, A., Elia, G., Santoro, M. G. (1997) Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation Proc. Natl. Acad. Sci. USA 94,746-750[Abstract/Free Full Text]
  35. Beg, A. A., Baldwin, A. S., Jr (1993) The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors Genes Dev 7,2064-2070[Free Full Text]
  36. Gilmore, T. D., Morin, P. J. (1993) The I kappa B proteins: members of a multifunctional family Trends Genet 9,427-433[Medline]
  37. Perkins, N. D. (2000) The Rel/NF-kappa B family: friend and foe Trends Biochem. Sci. 25,434-440[Medline]
  38. Santella, L., Bolsover, S. (1999) E. A. K. Caratoli, C. eds. Calcium in the Nucleus as a Cellular Regulator ,487-511 Oxford University Press New York.
  39. Ciapa, B., Pesando, D., Wilding, M., Whitaker, M. (1994) Cell-cycle calcium transients driven by cyclic changes in inositol trisphosphate levels Nature 368,875-878[Medline]
  40. Misra, U. K., Pizzo, S. V. (1998) Ligation of the {alpha}2M signaling receptor with receptor-recognized forms of {alpha}2-macroglobulin initiates protein and DNA synthesis in macrophages. The effect of intracellular calcium Biochim. Biophys. Acta 1401,121-128[Medline]
  41. Casey, P. J. (1995) Protein lipidation in cell signaling Science 268,221-225[Abstract/Free Full Text]
  42. Montminy, M. (1997) Transcriptional regulation by cyclic AMP Annu. Rev. Biochem. 66,807-822[Medline]
  43. Shaywitz, A. J., Greenberg, M. E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals Annu. Rev. Biochem. 68,821-861[Medline]
  44. Pardee, A. B. (1989) G1 events and regulation of cell proliferation Science 246,603-608[Abstract/Free Full Text]
  45. Karin, M. (1994) Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors Curr. Opin. Cell Biol. 6,415-424[Medline]
  46. Ryan, K. M., Birnie, G. D. (1996) Myc oncogenes: the enigmatic family Biochem. J. 314,713-721



This article has been cited by other articles:


Home page
Crit. Rev. Oral Biol. Med.Home page
L. Li
THE BIOCHEMISTRYAND PHYSIOLOGYOF METALLIC FLUORIDE: ACTION, MECHANISM, AND IMPLICATIONS
Crit. Rev. Oral. Biol. Med., March 1, 2003; 14(2): 100 - 114.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Misra, U. K.
Right arrow Articles by Pizzo, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Misra, U. K.
Right arrow Articles by Pizzo, S. V.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS